Demant A/S
WILLFOTCHealthcare● Active
$38.78
+$3.33(+9.39%)
Market Cap$8.2B
P/E Ratio—
52W High$43.775
52W Low$28.08
Demant A/S（WILLF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · WILLF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $2.36B | $4.53B | $4.15B | $3.21B | $3.44B |
| Depreciation & Amort. | $1.52B | $1.44B | $1.33B | $1.18B | $1.09B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.04B | $0.03B | $0.02B |
| Change in Working Capital | ($0.09B) | ($0.16B) | $0.01B | ($1.01B) | ($0.46B) |
| Net Cash from Operations | $3.95B | $4.08B | $4.23B | $2.37B | $3.27B |
| Investing Activities | |||||
| Capital Expenditure | ($0.65B) | ($0.78B) | ($0.64B) | ($0.92B) | ($0.72B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($7.04B) | ($1.83B) | ($1.77B) | ($3.33B) | ($1.30B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.58B) | ($2.30B) | ($0.85B) | ($1.84B) | ($3.20B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $4.68B | $0.81B | ($0.89B) | $3.39B | ($0.43B) |
| Net Cash from Financing | $3.35B | ($2.24B) | ($2.41B) | $0.93B | ($1.78B) |
| Free Cash Flow | |||||
| Free Cash Flow | $3.29B | $3.30B | $3.58B | $1.70B | $2.55B |
| FCF Margin %(computed) | 14.31% | 14.72% | 15.96% | 8.62% | 14.26% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · DKK · B
深入了解Demant A/S
关于Demant A/S（WILLF）现金流量表
Demant A/S 2025财年经营活动现金流$3.95B，自由现金流$3.29B（FCF利润率14.31%），资本支出($0.65B)。
常见问题
WILLF · 4 问Demant A/S 2025财年自由现金流$3.29B，同比down0.2%。
WILLF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10